acute lymphoblastic leukemia

Research in Review
Risk Stratification, Therapy Intensification Improves Prognosis in Adult ALL
06/29/2017
JCP Editors
Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...
Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...
Adult...
06/29/2017
Journal of Clinical Pathways
Research in Review
Leukemia Survival Outcomes Differ Between Sites of Care
04/11/2017
JCP Editors
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
Sites...
04/11/2017
Journal of Clinical Pathways
Research in Review
B-Cell ALL Disease Burden May Influence CAR T-Cell Therapy Impact on Survival
04/10/2017
JCP Editors
CD19-specific chimeric antigen receptor (CAR) T-cell therapy is more likely to be effective when given immediately after front-line therapy rather than after relapse in certain patients with B-cell acute...
CD19-specific chimeric antigen receptor (CAR) T-cell therapy is more likely to be effective when given immediately after front-line therapy rather than after relapse in certain patients with B-cell acute...
...
04/10/2017
Journal of Clinical Pathways
Research in Review
New Treatment Effective for B-Cell Precursor ALL in Pediatric Patients
11/17/2016
JCP Editors
Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...
Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...
...
11/17/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use